STOCK TITAN

INSPIRE VETERINARY PARTNER Financials

IVP
Source SEC Filings (10-K/10-Q) Data as of Sep 30, 2025 Currency USD FYE December

This page shows INSPIRE VETERINARY PARTNER (IVP) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI IVP FY2024

External financing is keeping operations running because roughly flat revenue cannot, on its own, carry a steadily heavier overhead load.

Between FY2023 and FY2024, net losses stayed at roughly the same level, but operating cash burn deepened from -$3.8M to -$10.0M. With capex only $238K, the extra cash drain came mainly from the business itself rather than from expansion spending, a sign that accounting losses understated cash consumption and that the operating model was becoming more cash-hungry.

Revenue barely moved in FY2024, yet operating margin worsened from -43.0% to -54.4%, which means scale did not improve cost absorption from the same revenue base. Selling and administrative costs kept taking a bigger bite of sales, so the company became less efficient even without a meaningful top-line decline.

In FY2024, financing inflows of $10.6M roughly matched operating cash burn of -$10.0M, showing outside capital was effectively replacing internally generated cash. That dependence remained despite a return to positive equity, because cash was only $524K and the current ratio stayed at 0.2x.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&D Intensity Revenue Progress Burn Trend Balance Sheet 16 / 100
Financial Health Score 16/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2024. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of INSPIRE VETERINARY PARTNER's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
3
Revenue Progress
78
Burn Trend
8
Balance Sheet
8
Altman Z-Score Distress
-3.41

INSPIRE VETERINARY PARTNER scores -3.41, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($4.0M) relative to total liabilities ($18.6M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
3/6

INSPIRE VETERINARY PARTNER passes 3 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Low Quality
0.70x

For every $1 of reported earnings, INSPIRE VETERINARY PARTNER generates $0.70 in operating cash flow (-$10.0M OCF vs -$14.3M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$16.6M
YoY-0.5%

INSPIRE VETERINARY PARTNER generated $16.6M in revenue in fiscal year 2024. This represents a decrease of 0.5% from the prior year.

EBITDA
-$7.7M
YoY-29.8%

INSPIRE VETERINARY PARTNER's EBITDA was -$7.7M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 29.8% from the prior year.

Net Income
-$14.3M
YoY+3.6%

INSPIRE VETERINARY PARTNER reported -$14.3M in net income in fiscal year 2024. This represents an increase of 3.6% from the prior year.

EPS (Diluted)
N/A

Cash & Balance Sheet

Free Cash Flow
-$10.2M
YoY-143.6%

INSPIRE VETERINARY PARTNER generated -$10.2M in free cash flow in fiscal year 2024, representing cash available after capex. This represents a decrease of 143.6% from the prior year.

Cash & Debt
$524K
YoY+192.6%

INSPIRE VETERINARY PARTNER held $524K in cash against $12.0M in long-term debt as of fiscal year 2024.

Dividends Per Share
N/A
Shares Outstanding
N/A

Margins & Returns

Gross Margin
N/A
Operating Margin
-54.4%
YoY-11.4pp

INSPIRE VETERINARY PARTNER's operating margin was -54.4% in fiscal year 2024, reflecting core business profitability. This is down 11.4 percentage points from the prior year.

Net Margin
-86.0%
YoY+2.7pp

INSPIRE VETERINARY PARTNER's net profit margin was -86.0% in fiscal year 2024, showing the share of revenue converted to profit. This is up 2.7 percentage points from the prior year.

Return on Equity
-913.2%

INSPIRE VETERINARY PARTNER's ROE was -913.2% in fiscal year 2024, measuring profit generated per dollar of shareholder equity.

Capital Allocation

R&D Spending
N/A
Share Buybacks
$650K

INSPIRE VETERINARY PARTNER spent $650K on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures
$238K
YoY-38.0%

INSPIRE VETERINARY PARTNER invested $238K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 38.0% from the prior year.

IVP Income Statement

Metric Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23
Revenue $4.3M+0.8% $4.3M+17.7% $3.6M+9.6% $3.3M-18.0% $4.0M-7.8% $4.4M-9.1% $4.8M+27.7% $3.8M
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $2.4M-8.6% $2.7M+8.3% $2.4M-26.8% $3.3M+11.8% $3.0M+34.7% $2.2M-22.8% $2.9M+29.0% $2.2M
Operating Income -$2.0M+24.8% -$2.6M-30.3% -$2.0M-30.7% -$1.5M+31.3% -$2.2M+6.6% -$2.4M+16.4% -$2.9M-19.0% -$2.4M
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income -$2.5M+16.8% -$3.0M-25.7% -$2.4M+39.1% -$4.0M-13.7% -$3.5M-3.0% -$3.4M+1.0% -$3.4M+17.4% -$4.1M
EPS (Diluted) N/A N/A N/A N/A N/A N/A N/A N/A

IVP Balance Sheet

Metric Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23
Total Assets $24.0M+15.1% $20.8M+0.7% $20.7M+2.3% $20.2M-9.8% $22.4M+2.1% $21.9M-6.3% $23.4M+7.4% $21.8M
Current Assets $3.8M+186.9% $1.3M-54.0% $2.9M+43.4% $2.0M-54.5% $4.5M+102.1% $2.2M-29.9% $3.1M+132.2% $1.4M
Cash & Equivalents $576K+46.5% $393K-78.8% $1.9M+254.8% $524K-23.1% $681K+8795.3% $8K-88.9% $69K-61.4% $179K
Inventory $498K+4.3% $477K+0.4% $475K-8.0% $517K-8.3% $564K-1.9% $575K+5.3% $546K-4.5% $572K
Accounts Receivable $29K-84.4% $184K+4096.4% $4K-89.2% $41K-64.8% $116K+190.9% $40K-88.4% $341K+1095.1% $29K
Goodwill $9.1M+1.1% $9.0M+12.0% $8.0M0.0% $8.0M0.0% $8.0M-1.5% $8.1M0.0% $8.1M0.0% $8.1M
Total Liabilities $19.8M-2.8% $20.4M+15.3% $17.7M-5.2% $18.6M-3.8% $19.4M-22.7% $25.0M+8.3% $23.1M+2.4% $22.6M
Current Liabilities $9.7M-3.3% $10.1M+34.5% $7.5M-8.9% $8.2M+16.7% $7.0M-43.4% $12.4M+46.9% $8.5M+11.5% $7.6M
Long-Term Debt $11.8M-2.3% $12.0M+4.4% $11.5M-3.8% $12.0M-3.6% $12.4M-14.9% $14.6M N/A N/A
Total Equity $4.2M+834.1% $446K-85.1% $3.0M+92.3% $1.6M-48.4% $3.0M+197.3% -$3.1M-1254.1% $270K+134.2% -$788K
Retained Earnings -$44.3M-6.0% -$41.8M-7.8% -$38.8M-6.6% -$36.4M-14.5% -$31.7M-12.4% -$28.2M-13.7% -$24.8M-17.1% -$21.2M

IVP Cash Flow Statement

Metric Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23
Operating Cash Flow -$1.3M-42.8% -$898K+34.6% -$1.4M-102.8% -$678K+89.3% -$6.3M-4314.0% $150K+104.7% -$3.2M-319.9% -$755K
Capital Expenditures $43K+245.5% $13K-38.0% $20K-36.3% $32K+24.7% $26K+7.7% $24K-84.9% $157K+563.7% $24K
Free Cash Flow -$1.3M-45.6% -$911K+34.7% -$1.4M-96.6% -$709K+88.8% -$6.3M-5126.4% $126K+103.8% -$3.3M-327.3% -$778K
Investing Cash Flow -$43K+97.7% -$1.9M-9086.6% -$20K+36.3% -$32K-24.7% -$26K-7.7% -$24K+84.9% -$157K+89.6% -$1.5M
Financing Cash Flow $1.5M+16.4% $1.3M-48.7% $2.5M+358.3% $552K-92.1% $7.0M+3838.7% -$187K-105.8% $3.2M+371.0% $683K
Dividends Paid N/A N/A N/A $0 $0-100.0% $9K-96.0% $212K+54.5% $137K
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

IVP Financial Ratios

Metric Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin -45.6%+15.5pp -61.1%-5.9pp -55.2%-8.9pp -46.2%+9.0pp -55.2%-0.7pp -54.5%+4.7pp -59.3%+4.3pp -63.6%
Net Margin -58.5%+12.3pp -70.8%-4.5pp -66.4%+53.1pp -119.4%-33.3pp -86.2%-9.1pp -77.1%-6.3pp -70.8%+38.6pp -109.5%
Return on Equity -60.6%+619.4pp -680.0%-599.6pp -80.4%+173.5pp -253.9%-138.8pp -115.2% N/A -1268.0% N/A
Return on Assets -10.5%+4.0pp -14.6%-2.9pp -11.7%+7.9pp -19.6%-4.1pp -15.6%-0.1pp -15.4%-0.8pp -14.6%+4.4pp -19.0%
Current Ratio 0.39+0.3 0.13-0.3 0.39+0.1 0.25-0.4 0.63+0.5 0.18-0.2 0.37+0.2 0.18
Debt-to-Equity 2.82-24.1 26.96+23.1 3.84-3.8 7.67+3.6 4.10+8.8 -4.69-90.4 85.70+114.3 -28.64
FCF Margin -30.7%-9.5pp -21.3%+17.1pp -38.3%-17.0pp -21.4%+135.1pp -156.4%-159.3pp 2.9%+71.7pp -68.8%-48.3pp -20.6%

Note: The current ratio is below 1.0 (0.25), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

INSPIRE VETERINARY PARTNER (IVP) reported $16.6M in total revenue for fiscal year 2024. This represents a -0.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

INSPIRE VETERINARY PARTNER (IVP) revenue declined by 0.5% year-over-year, from $16.7M to $16.6M in fiscal year 2024.

No, INSPIRE VETERINARY PARTNER (IVP) reported a net income of -$14.3M in fiscal year 2024, with a net profit margin of -86.0%.

INSPIRE VETERINARY PARTNER (IVP) had EBITDA of -$7.7M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2024, INSPIRE VETERINARY PARTNER (IVP) had $524K in cash and equivalents against $12.0M in long-term debt.

INSPIRE VETERINARY PARTNER (IVP) had an operating margin of -54.4% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

INSPIRE VETERINARY PARTNER (IVP) had a net profit margin of -86.0% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

INSPIRE VETERINARY PARTNER (IVP) has a return on equity of -913.2% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

INSPIRE VETERINARY PARTNER (IVP) generated -$10.2M in free cash flow during fiscal year 2024. This represents a -143.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

INSPIRE VETERINARY PARTNER (IVP) generated -$10.0M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

INSPIRE VETERINARY PARTNER (IVP) had $20.2M in total assets as of fiscal year 2024, including both current and long-term assets.

INSPIRE VETERINARY PARTNER (IVP) invested $238K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

Yes, INSPIRE VETERINARY PARTNER (IVP) spent $650K on share buybacks during fiscal year 2024, returning capital to shareholders by reducing shares outstanding.

INSPIRE VETERINARY PARTNER (IVP) had a current ratio of 0.25 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.

INSPIRE VETERINARY PARTNER (IVP) had a debt-to-equity ratio of 7.67 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

INSPIRE VETERINARY PARTNER (IVP) had a return on assets of -70.6% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2024 data, INSPIRE VETERINARY PARTNER (IVP) had $524K in cash against an annual operating cash burn of $10.0M. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

INSPIRE VETERINARY PARTNER (IVP) has an Altman Z-Score of -3.41, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

INSPIRE VETERINARY PARTNER (IVP) has a Piotroski F-Score of 3 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

INSPIRE VETERINARY PARTNER (IVP) has an earnings quality ratio of 0.70x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

INSPIRE VETERINARY PARTNER (IVP) scores 16 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top